IDO1 overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

IDO1 overexpression	Melanoma	IDO1 overexpression	Melanoma	PD1 inhibitor Sensitive: C3 – Early Trials PD1 inhibitor Sensitive : C3	PD1 inhibitor Sensitive: C3 – Early Trials PD1 inhibitor Sensitive : C3
IDO1 overexpression	Squamous Cell Carcinoma of Head and Neck	IDO1 overexpression	Squamous Cell Carcinoma of Head and Neck	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3

Associations